Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about GLP/1 drugs
Recent news which mentions GLP/1 drugs
Bernie Sanders: 'Ozempic Will Likely Become One Of The Best-Selling Pharmaceutical Products In History' — Americans Shouldn't Pay 10-15X More
June 26, 2024
Tickers
GLP
NEWS
NVO
Tags
NVO
Health Care
Vermont
From
Benzinga
New Weight Loss ETF Is Essentially A Play On Eli Lilly, Novo Nordisk
May 30, 2024
Tickers
LLY
NVO
OZEM
Tags
Specialty ETFs
NVO
Top Stories
From
Benzinga
Mangoceuticals Develops Oral GLP-1s: Stock Soars
May 21, 2024
Tickers
MGRX
NEWS
Tags
why it's moving
Market News
MGRX
From
Benzinga
Two Big Upside Risks To Watch
March 04, 2024
Tickers
AI
Tags
Benzinga
AI
contributors
From
Benzinga
Goldman Sachs: Eli Lilly's Shares May Surge By 140% With GLP-1 Drug Boom
December 19, 2023
Tickers
LLY
Tags
Biotech
Benzinga
Stories That Matter
From
Benzinga
Bernie Sanders To Take On Ozempic, Wegovy, Weight Loss Drugs: 'Could Be Helpful, But They're Not Going To Be Helpful If People Can't Afford Them'
December 08, 2023
Tickers
ALT
LLY
NVO
PFE
Tags
pharmaceutical stocks
PFE
Biotech
From
Benzinga
Jim Cramer Highlights 'Transformational' Impact Of Weight Loss Drugs Like Ozempic: Focus Now On 'Potential Winners' From The Same Narrative
December 04, 2023
Tickers
LLY
NVO
RHHBY
Tags
Market News
Eli Lilly & Co/
Jim Cramer
From
Benzinga
Wegovy, Ozempic Could Save 139,400 Lives In US Each Year; Novo Nordisk Heart Attack Research Reveals New Benefits
August 08, 2023
Tickers
LLY
NVO
Tags
Markets
Market News
NVO
From
Benzinga
As Drugs Like Ozempic And Mounjaro Disrupt The Weigh Loss Market, Who Stands To Win — And Who Stands To Lose?
April 18, 2023
Tickers
LLY
NVO
PLNT
PTON
Tags
PTON
General
Weight Loss
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.